GlassScriptPhysician profile
Cornelius A Wilson
NPI 1215032586
$677.67
in general payments reported to CMS, 2019-2025
14 companies · $79.95 in 2025
The $79.95 reported for 2025 was less than what a typical Adolescent Medicine (Internal Medicine) provider received nationally (typical 2025 total: $165).
See the full distribution for Adolescent Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $313 · 2020: $71.23 · 2022: $31.21 · 2023: $59.30 · 2024: $123 · 2025: $79.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $261.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $133.44 | 2019-2020 | |
| Boston Scientific Corporation | $116.47 | 2019 | |
| Cranial Technologies, INC | $112.47 | 2019-2025 | Doc Band |
| Supernus Pharmaceuticals, INC. | $50.03 | 2022-2024 | Qelbree, Qelbree |
| Phadia US INC. | $46.64 | 2019-2024 | Immunocap |
| Kowa Pharmaceuticals America, INC. | $37.21 | 2025 | Zoryve |
| Astrazeneca Pharmaceuticals LP | $33.60 | 2024 | Airsupra |
| Jazz Pharmaceuticals INC. | $31.53 | 2024 | |
| Exact Sciences Corporation | $28.94 | 2025 | Cologuard Collection Kit |
| Cumberland Pharmaceuticals, INC. | $22.71 | 2019 | |
| Ironshore Pharmaceuticals INC. | $20.47 | 2019 | |
| Ironwood Pharmaceuticals, INC | $17.58 | 2024 | |
| Alk-Abello, INC | $15.34 | 2023 | Grastek, Odactra |
| Tris Pharma INC | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cornelius Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.